Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

CHE PEER ANALYSIS

Chemed Corp — metric-by-metric comparison with peers and the industry median

CHEChemed Corp

🇺🇸 USA · NYSE · Healthcare · Medical Care Facilities

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Medical Care Facilities

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
CHEIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
CHE+5.9%RHC+11.7%FME-8.3%MPARK+19.3%SIA+29.3%FRE+5.2%
Year-to-Date (YTD)
CHE+13.7%RHC+26.5%FME+7.9%MPARK+11.2%SIA+15.3%FRE-8.9%
1-Year
Split-adjusted
CHE+5.9%UHS-10.8%ENSG+15.9%LFST+133.2%EHC-6.8%CON+57.2%
Year-to-Date (YTD)
CHE+13.7%UHS-25.9%ENSG-1.9%LFST+54.8%EHC+4.7%CON+61.6%

Key Metric Comparison

P/E

Lower is better
CHE25.55RHC36.38FME12.32MPARK13.39SIA51.59FRE16.57Median 20.15

ROE

Higher is better
CHE25.6%RHC5.9%FME6.8%MPARK17.4%SIA6.1%FRE7.5%Median 7.6%

Net Margin

Higher is better
CHE10.2%RHC1.6%FME4.9%MPARK10.1%SIA4.3%FRE6.4%Median 3.7%

Revenue Growth

Higher is better
CHE2.1%RHC8.6%FME-0.7%MPARK13.0%SIA16.7%FRE4.2%Median 10.2%

P/E

Lower is better
CHE25.55UHS6.54ENSG28.01LFST185.65EHC18.32CON23.01Median 20.15

ROE

Higher is better
CHE25.6%UHS21.2%ENSG16.9%LFST1.6%EHC26.0%CON48.6%Median 7.6%

Net Margin

Higher is better
CHE10.2%UHS8.6%ENSG6.9%LFST1.6%EHC10.0%CON8.0%Median 3.7%

Revenue Growth

Higher is better
CHE2.1%UHS10.4%ENSG19.2%LFST16.5%EHC10.0%CON15.5%Median 10.2%

All Metrics

Valuation
MetricCHERHCFMEMPARKSIAFREInd. Median
P/E25.5536.3812.32●13.3951.5916.5720.15
P/B7.831.970.88●1.912.711.231.87
EV/EBITDA16.4016.286.185.81●20.009.4911.23
P/S2.610.53●0.601.362.241.061.13
Financial Health
MetricCHERHCFMEMPARKSIAFREInd. Median
Current Ratio0.850.901.201.190.601.27●1.26
Debt/Equity27.9%●347.6%83.3%50.0%165.1%60.2%59.9%
NetDebt/EBITDA0.53●10.292.820.926.972.731.87
Profitability
MetricCHERHCFMEMPARKSIAFREInd. Median
Net Margin10.2%●1.6%4.9%10.1%4.3%6.4%3.7%
ROE25.6%●5.9%6.8%17.4%6.1%7.5%7.6%
ROA15.9%●1.4%2.9%8.3%2.0%3.4%3.0%
EBITDA Margin16.5%8.9%17.9%27.7%●17.2%15.6%13.8%
Growth + Dividend
MetricCHERHCFMEMPARKSIAFREInd. Median
Rev. Growth2.1%8.6%-0.7%13.0%16.7%●4.2%10.2%
NI Growth-15.9%1,044.7%●52.9%-17.4%31.7%248.3%17.0%
Div. Yield0.5%1.9%3.6%0.4%4.1%●2.5%1.1%
Payout12.5%62.5%44.7%5.9%154.7%46.3%12.7%
Valuation
MetricCHEUHSENSGLFSTEHCCONInd. Median
P/E25.556.54●28.01185.6518.3223.0120.15
P/B7.831.32●4.302.914.429.551.87
EV/EBITDA16.405.35●19.9043.839.3914.2111.23
P/S2.610.56●1.932.881.841.821.13
Financial Health
MetricCHEUHSENSGLFSTEHCCONInd. Median
Current Ratio0.851.081.56●1.481.171.261.26
Debt/Equity27.9%68.1%94.9%13.3%●110.6%499.8%59.9%
NetDebt/EBITDA0.531.792.770.01●1.774.791.87
Profitability
MetricCHEUHSENSGLFSTEHCCONInd. Median
Net Margin10.2%●8.6%6.9%1.6%10.0%8.0%3.7%
ROE25.6%21.2%16.9%1.6%26.0%48.6%●7.6%
ROA15.9%●10.0%7.0%1.1%8.7%6.3%3.0%
EBITDA Margin16.5%15.7%11.3%6.6%24.1%●19.3%13.8%
Growth + Dividend
MetricCHEUHSENSGLFSTEHCCONInd. Median
Rev. Growth2.1%10.4%19.2%●16.5%10.0%15.5%10.2%
NI Growth-15.9%27.1%●17.4%—23.1%13.7%17.0%
Div. Yield0.5%0.5%0.2%—0.7%0.8%●1.1%
Payout12.5%3.3%4.0%—12.0%31.5%12.7%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CHE

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.